Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Quality of Life Research
Gepubliceerd in: Quality of Life Research 7/2012

01-09-2012

Psychometric evaluation of the Cystic Fibrosis Questionnaire-Revised in a national sample

Auteurs: Alexandra L. Quittner, Gregory S. Sawicki, Ann McMullen, Lawrence Rasouliyan, David J. Pasta, Ashley Yegin, Michael W. Konstan

Gepubliceerd in: Quality of Life Research | Uitgave 7/2012

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

The psychometric properties of a health-related quality of life (HRQOL) instrument, the Cystic Fibrosis Questionnaire-Revised (CFQ-R), were evaluated in a national sample of patients with cystic fibrosis (CF).

Methods

The Epidemiologic Study of CF is a national, multicenter, longitudinal cohort study containing CFQ-R and health outcomes data. Developmentally appropriate versions of the CFQ-R were available from 7,330 patients aged 6–70 years and a proxy version from 2,728 parents of school-age children. The CFQ-R was completed during a “stable” or “sick” visit before recording health outcomes such as weight, lung function, and pulmonary exacerbations.

Results

There were few floor and ceiling effects and strong internal consistency (Cronbach alpha ≥0.70) for most scales. The CFQ-R consistently discriminated between patients seen for sick-versus-well visits, and among stages of disease severity based on lung function. As predicted, women with CF reported worse HRQOL than men on scales not related to body image and weight. Strong parent–child agreement was found on scales measuring observable behaviors (respiratory symptoms). Convergence between CFQ-R scales and health outcomes provided evidence of construct validity.

Conclusions

The CFQ-R demonstrated robust psychometric properties and consistent associations with health outcomes in a large national sample.
vorige artikel The anemia impact measure (AIM): development and content validation of a patient-reported outcome measure of anemia symptoms and symptom impacts in cancer patients receiving chemotherapy
volgende artikel Erratum to: Psychometric evaluation of the Cystic Fibrosis Questionnaire-Revised in a national, US sample
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
2.
Fayers, P., & Hays, R. (Eds.). (2005). Assessing quality of life in clinical trials: Methods and practice (2nd ed.). New York: Oxford University Press.
3.
Retsch-Bogart, G. Z., Quittner, A. L., Gibson, R. L., Oermann, C. M., McCoy, K. S., Montgomery, A. B., et al. (2009). Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis. Chest, 135(5), 1223–1232.PubMedCrossRef
4.
Goss, C. H., & Quittner, A. L. (2007). Patient-reported outcomes in cystic fibrosis. Proceedings of the American Thoracic Society, 4(4), 378–386.PubMedCrossRef
5.
Quittner, A. L., Modi, A., & Cruz, I. (2008). Systematic review of health-related quality of life measures for children with respiratory conditions. Paediatric Respiratory Reviews, 9(3), 220–232.PubMedCrossRef
6.
Quittner, A. L., Modi, A. C., Wainwright, C., Otto, K., Kirihara, J., & Montgomery, A. B. (2009). Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection. Chest, 135(6), 1610–1618.PubMedCrossRef
7.
Quittner, A. L., Buu, A., Messer, M. A., Modi, A. C., & Watrous, M. (2005). Development and validation of The Cystic Fibrosis Questionnaire in the United States: A health-related quality-of-life measure for cystic fibrosis. Chest, 128(4), 2347–2354.PubMedCrossRef
8.
Kaplan, R. M., Anderson, J. P., Wu, A. W., Mathews, W. C., Kozin, F., & Orenstein, D. (1989). The Quality of Well-being Scale. Applications in AIDS, cystic fibrosis, and arthritis. Medical Care, 27(3 Suppl), S27–S43.PubMedCrossRef
9.
Ware, J. E., Jr., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30(6), 473–483.PubMedCrossRef
10.
Palermo, T. M., Long, A. C., Lewandowski, A. S., Drotar, D., Quittner, A. L., & Walker, L. S. (2008). Evidence-based assessment of health-related quality of life and functional impairment in pediatric psychology. Journal of Pediatric Psychology, 33, 983–996.PubMedCrossRef
11.
Scoggins, J. F., & Patrick, D. L. (2009). The use of patient-reported outcomes instruments in registered clinical trials: Evidence from ClinicalTrials.gov. Contemporary Clinical Trials, 30(4), 289–292.PubMedCrossRef
12.
Cystic Fibrosis Foundation Patient Registry. (2007). Annual data report 2007. Bethesda, MD: Cystic Fibrosis Foundation.
13.
Quittner, A. L., Barker, D. H., Snell, C., Grimley, M. E., Marciel, K. K., & Cruz, I. (2008). Prevalence and impact of depression in cystic fibrosis. Current Opinion in Pulmonary Medicine, 14(6), 582–588.PubMedCrossRef
14.
Smith, B. A., Modi, A. C., Quittner, A. L., & Wood, B. L. (2010). Depressive symptoms in children with cystic fibrosis and parents and its effects on adherence to airway clearance. Pediatric Pulmonology, 45(8), 756–763.PubMedCrossRef
15.
Rosenfeld, M., Davis, R., FitzSimmons, S., Pepe, M., & Ramsey, B. (1997). Gender gap in cystic fibrosis mortality. American Journal of Epidemiology, 145(9), 794–803.PubMedCrossRef
16.
Courtney, J. M., Bradley, J., McCaughan, J., O’Connor, T. M., Shortt, C., Bredin, C. P., et al. (2007). Predictors of mortality in adults with cystic fibrosis. Pediatric Pulmonology, 42(6), 525–532.PubMedCrossRef
17.
Briesacher, B.A., Quittner. A.L., Fouayzi, H., Zhang, J., & Swensen, A. (2011). Nationwide trends in the medical care costs of privately-insured patients with cystic fibrosis, 2001–2007. Pediatric Pulmonology, 46(8), 770–776.
18.
Sawicki, G. S., Sellers, D. E., & Robinson, W. M. (2009). High treatment burden in adults with cystic fibrosis: Challenges to disease self-management. Journal of Cystic Fibrosis, 8(2), 91–96.PubMedCrossRef
19.
Modi, A. C., & Quittner, A. L. (2003). Validation of a disease-specific measure of health-related quality of life for children with cystic fibrosis. Journal of Pediatric Psychology, 28(8), 535–545.PubMedCrossRef
20.
Henry, B., Aussage, P., Grosskopf, C., & Goehrs, J. M. (2003). Development of the Cystic Fibrosis Questionnaire (CFQ) for assessing quality of life in pediatric and adult patients. Quality of Life Research, 12(1), 63–76.PubMedCrossRef
21.
Quittner, A. L., Sweeny, S., Watrous, M., Munzenberger, P., Bearss, K., Gibson Nitza, A., et al. (2000). Translation and linguistic validation of a disease-specific quality of life measure for cystic fibrosis. Journal of Pediatric Psychology, 25(6), 403–414.PubMedCrossRef
22.
McCoy, K. S., Quittner, A. L., Oermann, C. M., Gibson, R. L., Retsch-Bogart, G. Z., & Montgomery, A. B. (2008). Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis. American Journal of Respiratory and Critical Care Medicine, 178(9), 921–928.PubMedCrossRef
23.
Donaldson, S. H., Bennett, W. D., Zeman, K. L., Knowles, M. R., Tarran, R., & Boucher, R. C. (2006). Mucus clearance and lung function in cystic fibrosis with hypertonic saline. New England Journal of Medicine, 354(3), 241–250.PubMedCrossRef
24.
Elkins, M. R., Robinson, M., Rose, B. R., Harbour, C., Moriarty, C. P., Marks, G. B., et al. (2006). A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. New England Journal of Medicine, 354(3), 229–240.PubMedCrossRef
25.
Accurso, F. J., Rowe, S. M., Clancy, J. P., Boyle, M. P., Dunitz, J. M., et al. (2010). Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. New England Journal of Medicine, 363, 1991–2003.PubMedCrossRef
26.
Cystic Fibrosis Foundation. (2010). Cystic Fibrosis Foundation Patient Registry: 2009 annual data report. Bethesda, MD: Cystic Fibrosis Foundation.
27.
Ware, J. E., Brook, R. H., Davies-Avery, A. R., Williams, K. N., Stewart, A., Rogers, W. H., et al. (1980). Conceptualization and measurement of health for adults in the health insurance study: Vol. I, model of health and methodology. Santa Monica: Rand Corporation. Pub. no. R-1987/1-HEW.
28.
Martin, J. L., Ford, C. B., Dyer-Friedman, J., Tang, J., & Huffman, L. C. (2004). Patterns of agreement between parent and child ratings of emotional and behavioral problems in an outpatient clinical setting: When children endorse more problems. Journal of Developmental and Behavioral Pediatrics, 25(3), 150–155.PubMedCrossRef
29.
Levi, R., & Drotar, D. (1998). Measuring health-related quality of life in children and adolescents: Implications for research and practice. Mahwah, NJ: Lawrence Erlbaum Associates Publishers.
30.
Havermans, T., Vreys, M., Proesmans, M., & De Boeck, C. (2006). Assessment of agreement between parents and children on health-related quality of life in children with cystic fibrosis. Child: Care, Health and Development, 32(1), 1–7.CrossRef
31.
Schmidt, A., Wenninger, K., Niemann, N., Wahn, U., & Staab, D. (2009). Health-related quality of life in children with cystic fibrosis: Validation of the German CFQ-R. Health and Quality of Life Outcomes, 7, 97.PubMedCrossRef
32.
Cruz, I., Marciel, K. K., Cheney, J., Wainwright, C., Campbell, M., & Quittner, A. L. (2009). The preschool cystic fibrosis questionnaire-revised: Initial validation results. Pediatric Pulmonology, 32(Suppl), 421 (Abstract).
33.
VanDevanter, D. R., Rasouliyan, L., Murphy, T. M., Morgan, W. J., Ren, C. L., Konstan, M. W., et al. (2005). Trends in the clinical characteristics of the U.S. cystic fibrosis patient population from 1995 to 2005. Pediatric Pulmonology, 43(8), 739–744.CrossRef
Metagegevens
Titel
Psychometric evaluation of the Cystic Fibrosis Questionnaire-Revised in a national sample
Auteurs
Alexandra L. Quittner
Gregory S. Sawicki
Ann McMullen
Lawrence Rasouliyan
David J. Pasta
Ashley Yegin
Michael W. Konstan
Publicatiedatum
01-09-2012
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 7/2012
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-011-0036-z

Andere artikelen Uitgave 7/2012

Quality of Life Research 7/2012 Naar de uitgave

OriginalPaper

Health-related quality of life changes associated with buprenorphine treatment for opioid dependence

OriginalPaper

Confirmatory factor analysis of the General Health Questionnaire (GHQ-12) in Spanish adolescents

OriginalPaper

Impact of diabetes mellitus on quality of life in patients with congestive heart failure

OriginalPaper

The prevalence of hearing impairment and its burden on the quality of life among adults with Medicare Supplement Insurance

OriginalPaper

Validity, reliability and responsiveness of the EQ-5D in German stroke patients undergoing rehabilitation

Brief Communication

Validation of the Swedish translation of the general self-efficacy scale